BioMedical Technology Solutions Holdings, Inc. (“BMTS”) announced today that industry-wide respected businessman, Manny Losada, has agreed to join the BMTS Board of Directors. Manny brings more than 25 years of domestic and international experience to BMTS in the Company’s quest to take the Demolizer® II to new levels in sales and rentals.
Manny has proven his ability to produce at a various large companies throughout his career including Medical Actions Industries, B. Braun Medical, Henry Schein and Caligor/MicrobioMedics, Inc. Mr. Losada was a team leader in mergers and acquisitions during his time at Caligor/MicrobioMedics by successfully completing five acquisitions of regional hospital suppliers to support a 5-year, double digit company growth rate.
Presently, Manny is the President of MedPro Associates. MedPro is an industry giant representing many organizations that specialize in healthcare and sell their products either through distribution agreements or directly to consumers within the market. Mr. Losada is responsible for the strategic growth and business developments of MedPro. With his extensive global experience, Mr. Losada will be integral to the growth of BioMedical Technology Solutions, the wholly-owned subsidiary of BMTS through which BMTS operates.
Don Cox, President and CEO of BMTS, stated, “We are truly excited that Manny has agreed to join our Board of Directors. With his tremendous experience and proven leadership, Manny understands what is needed to develop long term strategic growth. I have gotten to know Manny very well over the past few years. He is a strategic thinker that has a depth of the knowledge on the diverse healthcare industries that is extremely difficult to find. As we continue our expansion both domestically and internationally, Manny is going to be an invaluable resource to our team.”
BioMedical Technology Solutions appears to be getting ready to ramp up business. In mid-August, BioMedical announced that Gex Richardson resigned from the positions of Director and General Counsel to aggressively pursue international distribution and domestic rentals of the Demolizer® II on a full-time basis. Last week, the Company announced the returning of a half a million warrants by Mr. Cox for no consideration. Previous to those press releases, the Company announced more sales of the System to U.S. HealthWorks and the U.S. Department of Veteran Affairs. Mr. Cox also mentioned in these press releases that there have been ongoing negotiations with large corporations. These press releases and comments within in conjunction with the fact that U.S. HealthWorks had originally been doing a “trial” of the Demolizer® II System in select markets, that was admittedly a success, poses the question of “What is in store for BioMedical Technology Solutions and Demolizer® II sales and rentals?” Never one to speculate too heavily, but it seems as if pieces of the puzzle are pulling together. Time will tell.
More information on BioMedical Technology Solutions Holdings, Inc., the Demolizer II System and the investment opportunity presented by BMTL can be found on the Company’s website at www.bmtscorp.com.